Japanese health officials have initiated a trial for over-the-counter morning-after pills at selected pharmacies, marking a significant step in accessibility and reproductive healthcare. The trial, conducted by the Japan Pharmaceutical Association, is set to run until early 2024, determining the feasibility of a broader rollout.About the Pill: The pill, known by its brand name NorLevo, contains levonorgestrel and boasts an efficacy rate of 80%. Recommended for use within 72 hours after unprotected intercourse, the pill aims to provide a timely and accessible option for emergency contraception, according to Japan's health ministry and Kyodo News.Customers can acquire the pill at a cost ranging from 7,000 yen ($47) to 9,000 yen ($61) during the trial period. Currently available at 145 pharmacies across the country, Tokyo, Kanagawa, and Osaka are designated to have five to six participating pharmacies, while 44 other prefectures will each have two to three.How to Obtain Them: To access th...